無気肺(Atelectasis):世界の治験レビュー2014年下半期版

◆英語タイトル:Atelectasis Global Clinical Trials Review, H2, 2014
◆商品コード:GDHC2478CTIDB
◆発行会社(リサーチ会社):GlobalData
◆発行日:2014年12月22日
◆ページ数:53
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥270,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥540,000見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD7,500 ⇒換算¥810,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、世界における無気肺(Atelectasis) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。

・イントロダクション
  - 無気肺(Atelectasis)
  - 当レポートの概要
・無気肺(Atelectasis):各地域別治験状況
  - 各国の治験件数及び平均被験者数
   アジア太平洋の主要国における治験件数
   欧州の主要国における治験件数
   北米の主要国における治験件数
   中東・アフリカの主要国における治験件数
   中南米の主要国における治験件数
・G7諸国での治験件数
・G7諸国での治験件数:段階別
・G7諸国での治験件数:進捗状況別
・段階(フェーズ)別の治験件数:進行中の治験(段階別)
・進捗状況別の治験件数
・治験目標の達成状況
・未完了の治験件数
・一定期間に採用された被験者
・スポンサーの種類別治験件数
・有望なスポンサー
・有望な薬剤
・治験のプロファイル
  - 代表的な企業における治験概要
  - 代表的な大学・研究機関における治験概要
・5つの代表的な治験のプロファイル
【レポートの概要】

Atelectasis Global Clinical Trials Review, H2, 2014

Summary

GlobalData’s clinical trial report, “Atelectasis Global Clinical Trials Review, H2, 2014″ provides data on the Atelectasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Atelectasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Atelectasis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Atelectasis 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Atelectasis to Respiratory Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Atelectasis to Respiratory Clinical Trials 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Clinical Trial Overview of Top Institutes / Government 25
Dresden University of Technology 25
Clinical Trial Overview of Dresden University of Technology 25
Hospital Sirio-Libanes 26
Clinical Trial Overview of Hospital Sirio-Libanes 26
The University of Utah 27
Clinical Trial Overview of The University of Utah 27
Erasmus MC 28
Clinical Trial Overview of Erasmus MC 28
London Health Sciences Centre 29
Clinical Trial Overview of London Health Sciences Centre 29
Herlev Hospital 30
Clinical Trial Overview of Herlev Hospital 30
University of Oklahoma 31
Clinical Trial Overview of University of Oklahoma 31
University of Medicine and Dentistry New Jersey (Inactive) 32
Clinical Trial Overview of University of Medicine and Dentistry New Jersey (Inactive) 32
Massachusetts General Hospital 33
Clinical Trial Overview of Massachusetts General Hospital 33
Duke University 34
Clinical Trial Overview of Duke University 34
Five Key Clinical Profiles 35
Appendix 51
Abbreviations 51
Definitions 51
Research Methodology 52
Secondary Research 52
About GlobalData 53
Contact Us 53
Disclaimer 53
Source 53

List of Tables
Atelectasis Therapeutics, Global, Clinical Trials by Region, 2014* 6
Atelectasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Atelectasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Atelectasis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Atelectasis Therapeutics Clinical Trials, Europe, Top Countries, 2014* 10
Atelectasis Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Atelectasis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12
Atelectasis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 13
Proportion of Atelectasis to Respiratory Clinical Trials, G7 Countries (%), 2014* 14
Atelectasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Atelectasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Atelectasis to Respiratory Clinical Trials, E7 Countries (%), 2014* 17
Atelectasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18
Atelectasis Therapeutics, Global, Clinical Trials by Phase, 2014* 19
Atelectasis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 20
Atelectasis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Atelectasis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Atelectasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Atelectasis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 24
Atelectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Dresden University of Technology, 2014* 25
Atelectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Sirio-Libanes, 2014* 26
Atelectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Utah, 2014* 27
Atelectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2014* 28
Atelectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by London Health Sciences Centre, 2014* 29
Atelectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Herlev Hospital, 2014* 30
Atelectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oklahoma, 2014* 31
Atelectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Medicine and Dentistry New Jersey (Inactive), 2014* 32
Atelectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 33
Atelectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2014* 34

List of Figures
Atelectasis Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Atelectasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Atelectasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Atelectasis Therapeutics Clinical Trials, Europe, Top Countries (%), 2014* 10
Atelectasis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Proportion of Atelectasis to Respiratory Clinical Trials, G7 Countries (%), 2014* 14
Atelectasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Atelectasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Atelectasis to Respiratory Clinical Trials, E7 Countries (%), 2014* 17
Atelectasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18
Atelectasis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 19
Atelectasis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 20
Atelectasis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Atelectasis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Atelectasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Atelectasis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 24
GlobalData Methodology 52

【レポートのキーワード】

無気肺(Atelectasis)、治験、臨床試験、治験、治療薬

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[無気肺(Atelectasis):世界の治験レビュー2014年下半期版]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆